Does DEUCRAVACITINIB Cause Urinary tract infection? 16 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Urinary tract infection have been filed in association with DEUCRAVACITINIB (SOTYKTU). This represents 0.7% of all adverse event reports for DEUCRAVACITINIB.
16
Reports of Urinary tract infection with DEUCRAVACITINIB
0.7%
of all DEUCRAVACITINIB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Urinary tract infection From DEUCRAVACITINIB?
Of the 16 reports, 1 (6.3%) resulted in death, 3 (18.8%) required hospitalization.
Is Urinary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEUCRAVACITINIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does DEUCRAVACITINIB Cause?
Drug ineffective (228)
Acne (225)
Pruritus (187)
Rash (175)
Erythema (124)
Psoriasis (122)
Off label use (101)
Adverse event (74)
Mouth ulceration (72)
Folliculitis (65)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which DEUCRAVACITINIB Alternatives Have Lower Urinary tract infection Risk?
DEUCRAVACITINIB vs DEUTETRABENAZINE
DEUCRAVACITINIB vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DEUCRAVACITINIB vs DEVICE
DEUCRAVACITINIB vs DEXAMETHASONE
DEUCRAVACITINIB vs DEXAMETHASONE\DEXAMETHASONE